These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 15906768

  • 1. Effects of hepatocyte growth factor on rat inflammatory bowel disease models.
    Ohda Y, Hori K, Tomita T, Hida N, Kosaka T, Fukuda Y, Miwa H, Matsumoto T.
    Dig Dis Sci; 2005 May; 50(5):914-21. PubMed ID: 15906768
    [Abstract] [Full Text] [Related]

  • 2. Repeated enemas with hepatocyte growth factor selectively stimulate epithelial cell proliferation of injured mucosa in rats with experimental colitis.
    Setoyama H, Ido A, Numata M, Moriuchi A, Yamaji N, Tamai T, Funakawa K, Fujita H, Sakiyama T, Uto H, Oketani M, Tsubouchi H.
    Life Sci; 2011 Aug 15; 89(7-8):269-75. PubMed ID: 21763320
    [Abstract] [Full Text] [Related]

  • 3. Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats.
    Tahara Y, Ido A, Yamamoto S, Miyata Y, Uto H, Hori T, Hayashi K, Tsubouchi H.
    J Pharmacol Exp Ther; 2003 Oct 15; 307(1):146-51. PubMed ID: 12954797
    [Abstract] [Full Text] [Related]

  • 4. Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease.
    Arthur LG, Schwartz MZ, Kuenzler KA, Birbe R.
    J Pediatr Surg; 2004 Feb 15; 39(2):139-43; discussion 139-43. PubMed ID: 14966727
    [Abstract] [Full Text] [Related]

  • 5. Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease.
    Ido A, Numata M, Kodama M, Tsubouchi H.
    J Gastroenterol; 2005 Oct 15; 40(10):925-31. PubMed ID: 16261428
    [Abstract] [Full Text] [Related]

  • 6. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
    Zhao J, de Vera J, Narushima S, Beck EX, Palencia S, Shinkawa P, Kim KA, Liu Y, Levy MD, Berg DJ, Abo A, Funk WD.
    Gastroenterology; 2007 Apr 15; 132(4):1331-43. PubMed ID: 17408649
    [Abstract] [Full Text] [Related]

  • 7. Hepatocyte growth factor promotes colonic epithelial regeneration via Akt signaling.
    Kanayama M, Takahara T, Yata Y, Xue F, Shinno E, Nonome K, Kudo H, Kawai K, Kudo T, Tabuchi Y, Watanabe A, Sugiyama T.
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul 15; 293(1):G230-9. PubMed ID: 17412827
    [Abstract] [Full Text] [Related]

  • 8. Hepatocyte Growth Factor Facilitates Esophageal Mucosal Repair and Inhibits the Submucosal Fibrosis in a Rat Model of Esophageal Ulcer.
    Komaki Y, Kanmura S, Sasaki F, Maeda H, Oda K, Arima S, Tanoue S, Nasu Y, Hashimoto S, Mawatari S, Tsubouchi H, Ido A.
    Digestion; 2019 Jul 15; 99(3):227-238. PubMed ID: 30227416
    [Abstract] [Full Text] [Related]

  • 9. Hepatocyte growth factor facilitates the repair of large colonic ulcers in 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats.
    Numata M, Ido A, Moriuchi A, Kim I, Tahara Y, Yamamoto S, Hasuike S, Nagata K, Miyata Y, Uto H, Tsubouchi H.
    Inflamm Bowel Dis; 2005 Jun 15; 11(6):551-8. PubMed ID: 15905702
    [Abstract] [Full Text] [Related]

  • 10. Hepatocyte Growth Factor and MET Support Mouse Enteric Nervous System Development, the Peristaltic Response, and Intestinal Epithelial Proliferation in Response to Injury.
    Avetisyan M, Wang H, Schill EM, Bery S, Grider JR, Hassell JA, Stappenbeck T, Heuckeroth RO.
    J Neurosci; 2015 Aug 19; 35(33):11543-58. PubMed ID: 26290232
    [Abstract] [Full Text] [Related]

  • 11. Hepatocyte growth factor ameliorates mucosal injuries leading to inhibition of colon cancer development in mice.
    Yamaji N, Ido A, Moriuchi A, Numata M, Setoyama H, Tamai T, Funakawa K, Fujita H, Sakiyama T, Uto H, Oketani M, Tsubouchi H.
    Oncol Rep; 2011 Aug 19; 26(2):335-41. PubMed ID: 21567095
    [Abstract] [Full Text] [Related]

  • 12. Erythropoietin attenuates intestinal inflammation and promotes tissue regeneration.
    Nakamura S, Sho M, Koyama F, Ueda T, Nishigori N, Inoue T, Nakamoto T, Fujii H, Yoshikawa S, Inatsugi N, Nakajima Y.
    Scand J Gastroenterol; 2015 Aug 19; 50(9):1094-102. PubMed ID: 25861881
    [Abstract] [Full Text] [Related]

  • 13. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M, Pichyangkura R, Soodvilai S, Chatsudthipong V, Muanprasat C.
    Pharmacol Res; 2012 Jul 19; 66(1):66-79. PubMed ID: 22475725
    [Abstract] [Full Text] [Related]

  • 14. Hepatocyte growth factor and omega-3-enriched feeds have a synergistic effect on mucosal mass in an animal model of inflammatory bowel disease.
    Katz MS, Thatch KA, Schwartz MZ.
    J Pediatr Surg; 2012 Jan 19; 47(1):194-8. PubMed ID: 22244416
    [Abstract] [Full Text] [Related]

  • 15. Mucosa repair mechanisms of Tong-Xie-Yao-Fang mediated by CRH-R2 in murine, dextran sulfate sodium-induced colitis.
    Gong SS, Fan YH, Wang SY, Han QQ, Lv B, Xu Y, Chen X, He YE.
    World J Gastroenterol; 2018 Apr 28; 24(16):1766-1778. PubMed ID: 29713130
    [Abstract] [Full Text] [Related]

  • 16. Gene alterations and intestinal mucosal changes following growth factor and omega-3 exposure in a rat model of inflammatory bowel disease.
    Katz MS, Thatch KA, Schwartz MZ.
    J Pediatr Surg; 2013 Feb 28; 48(2):345-52. PubMed ID: 23414863
    [Abstract] [Full Text] [Related]

  • 17. Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease.
    Khalil PN, Weiler V, Nelson PJ, Khalil MN, Moosmann S, Mutschler WE, Siebeck M, Huss R.
    Gastroenterology; 2007 Mar 28; 132(3):944-54. PubMed ID: 17383423
    [Abstract] [Full Text] [Related]

  • 18. Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model.
    Oh K, Iimuro Y, Takeuchi M, Kaneda Y, Iwasaki T, Terada N, Matsumoto T, Nakanishi K, Fujimoto J.
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr 28; 288(4):G729-35. PubMed ID: 15550554
    [Abstract] [Full Text] [Related]

  • 19. Hepatocyte growth factor is a potent promoter of mitogenesis in cultured rat visceral glomerular epithelial cells.
    Kawaguchi M, Kawashima F, Ohshima K, Kawaguchi S, Wada H.
    Cell Mol Biol (Noisy-le-grand); 1994 Dec 28; 40(8):1103-11. PubMed ID: 7873982
    [Abstract] [Full Text] [Related]

  • 20. Cannabinoid receptor 2 agonist promotes parameters implicated in mucosal healing in patients with inflammatory bowel disease.
    Tartakover Matalon S, Ringel Y, Konikoff F, Drucker L, Pery S, Naftali T.
    United European Gastroenterol J; 2020 Apr 28; 8(3):271-283. PubMed ID: 32213014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.